October 18, 2022
340B Court Case Note Highlights Nephron Depth & Breadth on Topic
October 7, 2022
Protected: KOL Views on CRC Screening – 10/5/22 – REPLAY
October 4, 2022
Protected: IRA22 Drug Price Controls: Impact & Implementation – 10/3 – Replay
October 4, 2022
Protected: NGS Updates Call With Dr. Chris Mason at Weill Cornell – 9/30 – REPLAY
September 30, 2022
BIIB’s Lecanemab: Enthusiasm vs Medicare Coverage Realities
September 28, 2022
Protected: Physician Enablement: The Second Inning A Symposium by Nephron Research – REPLAY
September 20, 2022
EQRX Initiation Brings New Perspective on Market Access/Biosims/IRA
September 9, 2022
Protected: KOL Call on NGS Innovation & Genomics – 9/8/22
September 6, 2022
CVS Acquisition of Signify Health – Implications for the Broader Physician Enablement Sector
August 26, 2022
Nephron Health Policy Team: Why MSSP is the Future for ACOs – Not ACO REACH
August 3, 2022
Protected: AACC Takeaways KOL Call for the Lab/Dx Industries – REPLAY
July 26, 2022
Protected: Gx Market Dynamics With Rx Sourcing Strategies and Smith Drug Co. – REPLAY
July 22, 2022
Physician Enablement Validation, AMZN/ONEM In Three Notes
July 15, 2022
Protected: Myriad Genetics (MYGN) PRIME Care Study KOL Call w/ Dr. Charlie Nemeroff – REPLAY
July 15, 2022
Protected: Medical Devices & Supplies Initiation – REPLAY